We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Bispecific antibodies (BsAbs) are artificially designed antibodies with dual binding sites. The binding sites may be directed at two different antigens or two different epitopes on the same antigen.
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer......